IP Library Assignment 064465/0383
Patent Assignment
Reel/Frame 064465/0383

Merger

Recorded: 2023-08-02 Pages: 6
Assignor
CONCERT PHARMACEUTICALS, INC.
Executed: 2023-03-28
Assignee
SUN PHARMACEUTICAL INDUSTRIES, INC.
2 INDEPENDENCE WAY, PRINCETON, NEW JERSEY, 08540
Covered Properties (73)
Biphenyl-Pyrazolecarboxamide Compounds
Patent: 7,514,068 →
Application: 11/521,926 →
Publication: US 2007/0066657
Deuterated Benzo[D][1,3]-Dioxol Derivatives
Patent: 7,678,914 →
Application: 11/704,554 →
Publication: US 2007/0191432
Deuterium Enriched Analogues of Tadalafil as PDE5 Inhibitors
Patent: 7,863,274 →
Application: 11/704,555 →
Publication: US 2007/0191381
Deuterated 3-(Dihydro-1H-Pyrazolo[4,3-D]Pyrimidin-5-Yl)-4-Propoxybenzenesulfonamide Derivatives and Methods of Use
Patent: 8,552,008 →
Application: 11/876,754 →
Publication: US 2008/0188496
Triazolyl Tropane Derivatives
Patent: 7,932,235 →
Application: 11/941,925 →
Publication: US 2008/0161264
Quinazoline Derivatives and Methods of Treatment
Patent: 8,343,950 →
Application: 11/957,442 →
Publication: US 2008/0166358
Alpha 1A-Adrenoceptor Antagonists
Patent: 8,013,007 →
Application: 12/072,501 →
Publication: US 2009/0012112
Oxazolidinone Derivatives and Methods of Use
Patent: 8,796,267 →
Application: 12/214,260 →
Publication: US 2009/0093422
Substituted Oxazolidinone Derivatives
Patent: 7,985,750 →
Application: 12/228,662 →
Publication: US 2009/0137535
Synthesis of Deuterated Catechols and Benzo[D][1,3]Dioxoles and Derivatives Thereof
Patent: 8,822,498 →
Application: 12/283,621 →
Publication: US 2009/0143432
Heterocyclic Kinase Inhibitors
Patent: 8,338,425 →
Application: 12/331,431 →
Publication: US 2009/0149399
Derivatives of Gefitinib
Patent: 7,855,204 →
Application: 12/358,238 →
Publication: US 2009/0185999
Synthesis of Deuterated Morpholine Derivatives
Patent: 8,354,557 →
Application: 12/456,507 →
Publication: US 2010/0160247
Substituted Triazolo-Pyridazine Derivatives
Patent: 8,003,646 →
Application: 12/550,346 →
Publication: US 2010/0056529
Deuterated Benzo[D][1,3]-Dioxol Derivatives
Patent: 8,450,492 →
Application: 12/688,466 →
Publication: US 2010/0222589
Azapeptide Derivatives
Patent: 8,158,805 →
Application: 12/755,184 →
Publication: US 2011/0009355
Substituted Isoindoline-1,3-Dione Derivatives
Patent: 8,124,646 →
Application: 12/816,295 →
Publication: US 2010/0324108
Substituted Triazolo-Pyridazine Derivatives
Patent: 8,501,738 →
Application: 12/820,570 →
Publication: US 2011/0065711
Substituted Triazolophthalazine Derivatives
Patent: 8,557,815 →
Application: 12/856,360 →
Publication: US 2011/0172235
Vandetanib Derivatives
Patent: 8,609,673 →
Application: 12/864,219 →
Publication: US 2011/0117084
Substituted Xanthine Derivatives
Patent: 8,952,016 →
Application: 12/874,049 →
Publication: US 2011/0059995
Deuterium Substituted Xanthine Derivatives
Patent: 8,263,601 →
Application: 12/874,783 →
Publication: US 2011/0077255
Substituted Benzimidazoles
Patent: 8,278,460 →
Application: 12/905,835 →
Publication: US 2011/0172280
Derivatives of Gefitinib
Patent: 9,133,137 →
Application: 12/946,856 →
Publication: US 2011/0059046
Derivatives of Dimethylcurcumin
Patent: 8,575,221 →
Application: 13/049,481 →
Publication: US 2011/0257271
Substituted Dioxopiperidinyl Phthalimide Derivatives
Patent: 9,045,453 →
Application: 13/107,873 →
Publication: US 2011/0288126
Deuterated 2-Amino-3-Hydroxypropanoic Acid Derivatives
Patent: 8,704,001 →
Application: 13/119,318 →
Publication: US 2011/0251131
Substituted Triazolo-Pyridazine Derivatives
Patent: 8,399,467 →
Application: 13/174,662 →
Publication: US 2012/0004236
Substituted Oxazolidinone Derivatives
Patent: 8,227,464 →
Application: 13/189,003 →
Publication: US 2011/0281828
Deuterated Pyrazinoisoquinoline Compounds
Patent: 8,563,554 →
Application: 13/256,787 →
Publication: US 2012/0149709
4-Hydroxybutyric Acid Analogs
Patent: 8,461,197 →
Application: 13/265,609 →
Publication: US 2012/0122952
Fluorinated Diaryl Urea Derivatives
Patent: 8,410,082 →
Application: 13/320,646 →
Publication: US 2012/0237474
Substituted Isoindoline-1,3-Dione Derivatives
Patent: 8,404,737 →
Application: 13/364,724 →
Publication: US 2012/0252864
4-Hydroxybutyric Acid Analogs
Patent: 8,759,394 →
Application: 13/372,989 →
Publication: US 2013/0012565
Substituted Derivatives of Bicyclic [4.3.0] Heteroaryl Compounds
Patent: 9,260,432 →
Application: 13/394,025 →
Publication: US 2012/0295925
Azapeptide Derivatives
Patent: 8,258,309 →
Application: 13/411,089 →
Publication: US 2012/0165288
Deuterated Pyrazinoisoquinoline Compounds
Patent: 8,889,687 →
Application: 13/411,198 →
Publication: US 2013/0029997
Deuterium-Substituted Xanthine Derivatives and Methods of Use
Patent: 8,987,442 →
Application: 13/448,930 →
Publication: US 2012/0202830
Substituted Isoindoline-1,3-Dione Derivatives
Patent: 8,883,843 →
Application: 13/721,911 →
Publication: US 2013/0345282
Process for Preparing an Enantiomerically Enriched, Deuterated Secondary Alcohol from a Corresponding Ketone Without Reducing Deuterium Incorporation
Patent: 9,074,233 →
Application: 13/819,985 →
Publication: US 2013/0280768
Process for Preparing an Enantiomerically Enriched, Deuterated Secondary Alcohol from a Corresponding Ketone Without Reducing Deuterium Incorporation
Patent: 9,085,788 →
Application: 13/820,003 →
Publication: US 2014/0017739
Substituted Triazolo-Pyridazine Derivatives
Patent: 8,921,366 →
Application: 13/846,119 →
Publication: US 2013/0225590
4-Hydroxybutyric Acid Analogs
Patent: 9,051,261 →
Application: 13/914,127 →
Publication: US 2014/0142179
Substituted Xanthine Derivatives
Patent: 9,035,050 →
Application: 13/949,888 →
Publication: US 2014/0121226
Substituted Triazolo-Pyridazine Derivatives
Patent: 8,993,570 →
Application: 13/959,716 →
Publication: US 2013/0317033
DEUTERATED PYRAZINO[2,1-a]ISOQUINOLINES FOR THE TREATMENT OF DISEASES AND/OR CONDITIONS
Patent: 9,199,986 →
Application: 14/030,617 →
Publication: US 2014/0107127
Deuterated Cftr Potentiators
Patent: 8,865,902 →
Application: 14/082,843 →
Publication: US 2014/0073667
Deuterated 2-Amino-3-Hydroxypropanoic Acid Derivatives
Patent: 9,108,902 →
Application: 14/220,770 →
Publication: US 2014/0221492
4-Hydroxybutyric Acid Analogs
Patent: 9,309,182 →
Application: 14/255,331 →
Publication: US 2014/0343119
Synthesis of Deuterated Catechols and Benzo[D][1,3]Dioxoles and Derivatives Thereof
Patent: 9,315,483 →
Application: 14/340,143 →
Publication: US 2014/0336387
Substituted Xanthine Derivatives
Patent: 9,328,113 →
Application: 14/391,443 →
Publication: US 2015/0119407
Deuterated Vercirnon
Patent: 9,181,190 →
Application: 14/412,169 →
Publication: US 2015/0175546
Deuterated Baricitinib
Patent: 9,540,367 →
Application: 14/422,049 →
Publication: US 2015/0218158
Solid Forms of {S-3-(4-Amino-1-Oxo-Isoindolin-2-Yl)(Piperidine-3,4,4,5,5-D5)-2,6-Dione}
Patent: 9,643,950 →
Application: 14/437,519 →
Publication: US 2015/0299162
Deuterated Cftr Potentiators
Patent: 9,181,192 →
Application: 14/490,787 →
Publication: US 2015/0099780
Substituted Isoindoline-1,3-Dione Derivatives
Patent: 9,296,689 →
Application: 14/490,859 →
Publication: US 2015/0105438
Methods of Use Comprising Deuterated Pyrazino[2,1-A]Isoquinolines
Patent: 9,206,179 →
Application: 14/518,254 →
Publication: US 2015/0141431
Synthesis of Deuterated Morpholine Derivatives
Patent: 9,453,009 →
Application: 14/566,244 →
Publication: US 2015/0099714
Substituted Xanthine Derivatives
Patent: 9,492,457 →
Application: 14/626,978 →
Publication: US 2015/0272956
Substituted Xanthine Derivatives
Patent: 9,493,463 →
Application: 14/713,423 →
Publication: US 2015/0322068
4-Hydroxybutyric Acid Analogs
Patent: 9,815,763 →
Application: 14/732,859 →
Publication: US 2015/0344398
Deuterated Momelotinib
Patent: 9,518,027 →
Application: 14/759,028 →
Publication: US 2015/0361051
Deuterated Cftr Potentiators
Patent: 9,512,079 →
Application: 14/921,158 →
Publication: US 2016/0039764
Deuterated Pyrazino[2,1-a]isoquinoline Compounds and Methods of Treatment Using the Same
Patent: 9,944,635 →
Application: 14/958,461 →
Publication: US 2016/0083385
4-Hydroxybutyric Acid Analogs
Application: 15/095,545 →
Publication: US 2016/0326086
Substituted Xanthine Derivatives
Patent: 9,918,987 →
Application: 15/291,764 →
Publication: US 2017/0027946
Deuterated Momelotinib
Patent: 9,776,973 →
Application: 15/364,516 →
Publication: US 2017/0144977
Deuterated Baricitinib
Patent: 9,931,343 →
Application: 15/378,168 →
Publication: US 2017/0189406
4-Hydroxybutyric Acid Analogs
Application: 15/810,526 →
Publication: US 2018/0155266
Substituted Xanthine Derivatives
Application: 15/922,265 →
Publication: US 2018/0333417
4-Hydroxybutyric Acid Analogs
Application: 16/739,422 →
Publication: US 2020/0385330
4-Hydroxybutyric Acid Analogs
Application: 17/164,391 →
Publication: US 2021/0403407
4-Hydroxybutyric Acid Analogs
Application: 17/514,416 →
Publication: US 2022/0162146
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 1, 2006
From: TUNG, ROGER
To: CONCERT PHARMACEUTICALS INC.
Reel/Frame 018578/0627 →
Assignment of Assignor's Interest Feb 8, 2007
From: TUNG, ROGER
To: CONCERT PHARMACEUTICALS INC.
Reel/Frame 018980/0539 →
Assignment of Assignor's Interest Mar 20, 2008
From: TUNG, ROGER
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 020680/0479 →
Assignment of Assignor's Interest Apr 18, 2008
From: TUNG, ROGER
To: CONCERT PHARMCEUTICALS, INC.
Reel/Frame 020823/0658 →
Assignment of Assignor's Interest Aug 19, 2008
From: LIU, JULIE F.
To: COCERT PHARMACEUTICALS, INC.
Reel/Frame 021406/0890 →
Re-Record to Correct the Spelling of Assignee's Name on a Document Previously Recorded at Reel 021406, Frame 0890. (Assignment of Assignor's Interest) Sep 25, 2008
From: LIU, JULIE F.
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 021594/0977 →
Assignment of Assignor's Interest Dec 10, 2008
From: TUNG, ROGER; HARBESON, SCOTT
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 021968/0380 →
Assignment of Assignor's Interest Feb 2, 2009
From: MASSE, CRAIG E.
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 022195/0263 →
Assignment of Assignor's Interest Feb 5, 2009
From: JONES, ANDREW D.; ZELLE, ROBERT E.; SILVERMAN, I. ROBERT
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 022211/0022 →
Assignment of Assignor's Interest Feb 19, 2009
From: TUNG, ROGER
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 022282/0845 →
Assignment of Assignor's Interest Apr 14, 2009
From: TUNG, ROGER
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 022544/0417 →
Assignment of Assignor's Interest Aug 26, 2009
From: TUNG, ROGER
To: CONCERT PHARMACEUTICALS INC.
Reel/Frame 023149/0973 →
Assignment of Assignor's Interest Oct 14, 2009
From: LIU, JULIE F.; TANG, XUEJUN; HARBESON, SCOTT L.; MASSE, CRAIG E.
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 023368/0416 →
Assignment of Assignor's Interest Jan 12, 2010
From: HARBESON, SCOTT
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 023766/0341 →
Assignment of Assignor's Interest Aug 27, 2010
From: LIU, JULIE F.
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 024897/0949 →
Assignment of Assignor's Interest Sep 1, 2011
From: HARBESON, SCOTT L.; TUNG, ROGER D.
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 026842/0177 →
Assignment of Assignor's Interest Nov 27, 2012
From: TUNG, ROGER D.
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 029354/0189 →
Assignment of Assignor's Interest May 13, 2015
From: TUNG, ROGER
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 035626/0951 →